Skip to content

Medical-device intelligence

GSO: Antigens (Febrile), Agglutination, Brucella Spp.

FDA product code GSO: Antigens (Febrile), Agglutination, Brucella Spp.. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GSO
FDA device name
Antigens (Febrile), Agglutination, Brucella Spp.
Device class
2
Regulation number
866.3085
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

12 clearance records and 2 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from Sep 24, 1979 to Oct 20, 2004.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GSO · Antigens (Febrile), Agglutination, Brucella Spp.122

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

14 matching records
Device / recordCompany in FDA recordSourceSource date
BD, Brucella melitensis AntigenZ-0311-05 · GSOBD Diagnostic SystemsRecallDec 16, 2004FDA classification date
BD, Brucella abortus AntigenZ-0314-05 · GSOBD Diagnostic SystemsRecallDec 16, 2004FDA classification date
VISTA ANTIGEN BRUCELLA ABORTUSK972394 · GSOLee Laboratories, Inc.510(k)Aug 25, 1997FDA decision date
VISTA ANTIGEN BRUCELLA MELITENSISK972396 · GSOLee Laboratories, Inc.510(k)Aug 25, 1997FDA decision date
SAS BRUCELLA SUIS ANTIGENK952139 · GSOSa Scientific, Inc.510(k)Jul 18, 1995FDA decision date
SAS FEBRILE ANTIGEN SETK952131 · GSOSa Scientific, Inc.510(k)Jul 17, 1995FDA decision date
SAS SALMONELLA H D ANTIGENK952135 · GSOSa Scientific, Inc.510(k)Jul 17, 1995FDA decision date
SAS SALMONELLA H B ANTIGENK952136 · GSOSa Scientific, Inc.510(k)Jul 17, 1995FDA decision date
SAS SALMONELLA H A ANTIGENK952137 · GSOSa Scientific, Inc.510(k)Jul 17, 1995FDA decision date
SAS BRUCELLA MELTIENSIS ANTIGENK952140 · GSOSa Scientific, Inc.510(k)Jul 17, 1995FDA decision date
SAS BRUCELLA ABORTUS ANTIGENK952147 · GSOSa Scientific, Inc.510(k)Jul 17, 1995FDA decision date
BRUCELLA IFA*K885112 · GSOInvestigacion Farmaceutica S.A. DE C.V.510(k)Aug 15, 1989FDA decision date
FEBRILE ANTIGEN KITK822663 · GSOOxoid U.S.A., Inc.510(k)Sep 21, 1982FDA decision date
AGGLUTINOTEST-BRUCELLAK791449 · GSOVolu Sol Medical Industries510(k)Sep 24, 1979FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗